Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Synonyms :
Class :
in combination with ofatumumab, inebilizumab increases the risk of adverse events
when both drugs are combined, there may be an increase in immunosuppressive activity and the risk of severe infection
may enhance the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of immunosuppressants
Immunosuppressants may enhance the immunosuppressive effect of Inebilizumab.
Immunosuppressants may enhance the immunosuppressive effect of Inebilizumab.
Immunosuppressants may enhance the immunosuppressive effect of Inebilizumab.
Immunosuppressants may enhance the immunosuppressive effect of Inebilizumab.
Immunosuppressants may enhance the immunosuppressive effect of Inebilizumab.
may have an increased immunosuppressive effect when combined with inebilizumab
may have an increased immunosuppressive effect when combined with inebilizumab
may have an increased immunosuppressive effect when combined with inebilizumab
may have an increased immunosuppressive effect when combined with inebilizumab
may have an increased immunosuppressive effect when combined with inebilizumab
inebilizumab: they may increase the immunosuppressive effect of immunostimulants
inebilizumab: they may increase the immunosuppressive effect of immunostimulants
inebilizumab: they may increase the immunosuppressive effect of immunostimulants
inebilizumab: they may increase the immunosuppressive effect of immunostimulants
inebilizumab: they may increase the immunosuppressive effect of immunostimulants
inebilizumab: they may increase the immunosuppressive effect of selective immunosuppressants
inebilizumab: they may increase the immunosuppressive effect of selective immunosuppressants
inebilizumab: they may increase the immunosuppressive effect of selective immunosuppressants
methotrexate may enhance the immunosuppressive effect of inebilizumab
trimetrexate may enhance the immunosuppressive effect of inebilizumab
pemetrexed may enhance the immunosuppressive effect of inebilizumab
combination may enhance the immunosuppressive effect and lead to serious infections
oncologic agents may enhance the immunosuppressive effects of inebilizumab
when both drugs are combined, there may be an increase in immunosuppressive activity and the risk of severe infection
may increase the immunosuppressive effect of immunosuppressants
may increase the immunosuppressive effect of Immunosuppressants